Libor Capital Look to Increase Investment in the UK Healthcare Sector
Libor Capital confirms Michael Patterson - Managing Partner & Founder will be attending the HealthInvestor Summit in London.
Toronto, Canada, August 9, 2015 (Newswire.com) - Mr. Patterson stated that “Libor Capital are looking to seriously increase their UK healthcare investments, there are many dynamic startups looking for the right investment partners and with our knowledge and expertise in this sector we believe we can take them to the next level and be serious players on the world stage”.
Libor Capital see themselves as a firm that has already successfully partnered various healthcare companies on home soil in Canada and believes the market in the UK health sector is huge and they intend taking a profitable slice of the pie.
HealthInvestor Summit
Date: 4 November 2015
Time: 09.00 - 17.30
Venue: Millennium Hotel London Mayfair
On 4 November HealthInvestor, the leading source of business information for UK healthcare, is hosting its fifth annual Summit – the leading conference for UK health and social care investment.
The HealthInvestor Summit brings together the major private healthcare providers, investors and industry experts alongside the key public sector figures driving innovation in UK healthcare.
The purpose of the event is to provide a single forum to consider the major challenges facing the sector and to hear first-hand from UK healthcare’s leading figures about the trends and opportunities that continue to attract investors to the market.
This year’s HealthInvestor Summit will address key topics including:
- State of play: What is the role of the private sector in today’s UK health and social care sector? Is this evolving?
- International exposure: Why have we seen so much foreign investment into the UK, and what impact is this having on the domestic market?
- 2015 so far: What’s driving deal activity?
- Supply and demand: Who are the buyers in today’s market, and what is there to buy?
- Buying in 2015: Where and what is the smart money targeting?
- CMA investigation: What are the lasting implications for the sector?
- Politics of privatization: Is independent sector involvement in health still politically toxic?